Photorhabdus species: bioluminescent bacteria as emerging human pathogens? – Dispatches
John G. Gerrard
We report two Australian patients with soft tissue infections due to Photorhabdus species. Recognized as important insect pathogens, Photorhabdus spp. are bioluminescent gram-negative bacilli. Bacteria belonging to the genus are emerging as a cause of both localized soft tissue and disseminated infections in humans in the United States and Australia. The source of infection in humans remains unknown.
Bioluminescence is the production of visible light by a chemical reaction in a living organism. The property is rarely reported in the clinical bacteriology laboratory because bacterial bioluminescence is seen primarily in marine species. Photorhabdus spp (family: Enterobacteriaceae) are the only terrestrial bacteria known to exhibit this property (1). The classification within the genus is complex with three currently recognized species: P. luminescens, P. temperata, and P. asymbiotica (2). Several subspecies are recognized.
Photorhabdus spp. have been the subject of intensive study by agricultural scientists because of the role these bacteria play in controlling insects. Insects, like humans, are subject to infestation by nematodes (3). Photorhabdus spp. inhabit the gut of some insect-pathogenic nematodes (Heterorhabditis spp.), where they form a symbiotic relationship. Nematode species of this type are able to invade the larvae of susceptible insects and release Photorhabdus spp. The bacteria proliferate and promote nematode reproduction by killing the insect larvae.
Insect-pathogenic nematodes harboring Photorhabdus spp are used as biopesticides in a number of countries, including the United States and Australia. Agricultural scientists are also attempting to develop insect-resistant transgenic crops by using insecticidal toxin genes derived from Photorhabdus spp. (4).
Genes encoding homologues of insecticidal toxins from Photorhabdus spp. occur naturally within the genome of Yersinia pestis, the cause of plague. Lateral transfer of genetic material between Photorhabdus and Yersinia species is thought to have resulted from their common association with insects as bacterial pathogens (5).
Human infection with Photorhabdus spp. has been described in two previous publications–six cases from the United States (6) and four cases from South Eastern Australia (Victoria and New South Wales) (1). We report two additional recent human cases of Photorhabdus infection from the Australian state of Queensland.
A 39-year-old male pest controller from Gladstone on a routine visit to his general practitioner in April 2001 inquired about the recent appearance of a red macule, 8 mm in diameter, on the medial aspect of his right ankle. No specific treatment was given. When he was seen again 18 days later, a painful, necrotic ulcer, about 12 mm in diameter, had developed at the original site of the red spot. A gram-negative organism later identified as Photorhabdus sp. was isolated in pure growth from the exudate. The patient began a 10-day course of oral cephalexin. When he was observed again 11 days later, he exhibited a persistent discharge with surrounding cellulitis. He was therefore prescribed a 10-day course of oral amoxycillin-clavulanate. Three weeks later, the ulcer appeared to be healing; after another 6 weeks, signs of infection had again developed. A gram-negative organism was isolated from the exudate but was not formally identified.
The patient was prescribed an additional 7-day course of oral cephalexin. When he was observed 3 months later, the infection had resolved. In his recent work as a pest controller, he had been spraying chemical insecticides under houses and in foreign cargo ships. He had never used insect pathogenic nematodes as a biopesticide.
A 78-year-old man from the Queensland Gold Coast sought treatment in January 1999 with a 3-day history of a painful, swollen right foot. The patient had a history of polymyalgia rheumatica for which he was taking prednisone, 8 mg daily. In January 1999, after working barefoot in the garden, the man noted intense pain in his right forefoot and a very small amount of bloody discharge from the web space between his fourth and fifth toes.
The next day he was seen by his general practitioner who treated him with oral dicloxacillin. Two days later he was admitted to the hospital with increasingly severe pain with extensive redness and swelling extending to his right knee. He was noted to be afebrile with a mild neutrophil leukocytosis. He was started on a regimen of intravenous dicloxacillin and gentamicin.
Surgical debridement of the right foot was required on three occasions during the first 8 days of his admission. Pus was collected for culture on two of these occasions, and tissue was obtained during the third. An organism identified as Photorhabdus sp. was isolated in pure culture from each of these operative specimens. The same organism was also isolated, together with Staphylococcus aureus, from a superficial swab collected in the emergency department on presentation. No bacterial growth was obtained from blood cultures collected on admission.
The patient was treated with intravenous gentamicin for 2 weeks and ceftazidime for 1 week. He was discharged on a 6-week course of oral ciprofloxacin. The foot remained healed on follow-up 3 months later.
Photorhabdus spp. can be isolated and identified to genus level by using techniques available in most clinical bacteriology laboratories. A total of five isolates from the two patients described in the current report were examined in our laboratories with standard techniques (one from patient 1 and four from patient 2). The phenotypic characteristics that the isolates displayed were typical of the genus.
Colonies were formed after 24-48 hours on tryptic soy agar containing either 5% sheep or horse blood (bioMerieux, Baulkham Hills, Australia) at both 35[degrees]C and at room temperature, with a tendency to “swarm” (Figure 1). The isolates also grew on MacConkey agar. On sheep and horse blood agar, a thin line of annular hemolysis was observed 4-12 mm from the colony edge. The hemolysis was more apparent when the isolates were incubated at room temperature (Figure 2). The organisms were motile, gram-negative, rod-shaped bacteria. They were facultatively anaerobic, oxidase negative, and strongly catalase positive. Other biochemical reactions were as described previously (1).
[FIGURES 1-2 OMITTED]
The defining characteristic was the presence of faint luminescence, which could be clearly seen with the naked eye when the colonies were examined under conditions of total darkness. It was critical to this examination that the observer’s eyes be allowed to adjust to the darkness for 10 minutes.
Two commercially available automated bacterial identification systems were used in our laboratories: MicroScan Walkaway (Dade Behring Inc., MicroScan Division, West Sacramento, CA) and bioMerieux Vitek (bioMerieux; Hazelwood, MO). Photorhabdus spp. do not currently appear on the databases of either of these systems, which leads to misidentification (Table 1).
Photorhabdus spp. have been shown to form a heterogeneous group based on DNA-DNA hybridization studies, 16S rDNA sequencing and polymerase chain reaction ribotyping (2). A polyphasic approach is now applied to classifying isolates within the genus, dividing it into three species and several subspecies. The American clinical isolates described by Farmer et al. (6) belong to a new species, Photorhabdus asymbiotica (2). A specific epithet has not yet been assigned to the Australian clinical isolates but they also may form a new species within the genus (7).
Antimicrobial sensitivity was assessed by using broth microdilution. The isolates were sensitive to a broad range of antimicrobial agents with activity against gram-negative bacteria including ciprofloxacin, gentamicin, tetracycline, ceftriaxone, and amoxycillin-clavulanate. Isolates from both patients were resistant to cephalothin and ampicillin.
Publication of information about these two cases brings to a total of 12 the number of human infections with Photorhabdus spp. documented in the medical literature (Table 2 and Figure 3). The clinical picture described in the 12 cases has generally been one of localized or more commonly multifocal skin/soft tissue infection. Such infection has had a tendency to relapse. The disseminated distribution of skin/soft tissue infection in several cases suggests hematogenous spread. Bacteremia was documented in 4/12 case-patients. Cough was documented in two of the bacteremic case-patients. In one of these, isolates of a Photorhabdus sp. were obtained from sputum as well as from blood and skin/soft tissue.
[FIGURE 3 OMITTED]
Given the very limited clinical experience, making definitive recommendations about treatment is not possible. Antimicrobial therapy should be guided by in vitro sensitivities. The tendency for Photorhabdus infection to relapse suggests that prolonged therapy for a period of weeks would be prudent, perhaps with an oral fluoroquinolone.
Photorhabdus spp. are not human commensals. The patients apparently acquired the pathogen from an unidentified source in the terrestrial environment. This hypothesis is supported by the observations that at least 4/6 of the Australian patients were engaged in outdoor activities around the time of acquisition and that the initial site of infection was on the lower limbs in more than half of Australian and American case-patients.
Photorhabdus spp. have never been shown to live freely in soil, although they will survive in soil under laboratory conditions (8). Photorhabdus spp. have only been isolated naturally from two nonclinical sources: insect-pathogenic nematodes (Heterorhabditis spp) and the insects they parasitize (beetles, moths, and the like). It seems likely therefore that Photorhabdus spp are transmitted to humans by a terrestrial invertebrate (nematode or arthropod), but that vector has not yet been identified.
Table 1. Misidentification of Photorhabdus isolates from patients 1
and 2 by commercially available bacterial identification systems
System Misidentification Probability
MicroScan Walkaway Rapid Shewanella putrefaciens 99.97%
Neg BP Combo Panel Type 4
MicroScan Walkaway Pseudomonas oryzihabitans 85.46%
Neg BP Combo Panel Type 11
BioMerieux Vitek Providencia stuartii 99%
Table 2. Published human cases of Photorhabdus infection
Case no. Year Country Location Age/sex
1 2001 Australia Gladstone, 39M
2 1999 Australia Gold Coast, 78M
3 (1) 1998 Australia Murwil-lumbah, 55M
New South Wales
4 (1) 1998 Australia Wangaratta, 50M
5 (1) 1998 Australia Melbourne, Victoria 90M
6 (1) 1994 Australia Melbourne, Victoria 11F
7 (6) 1989 USA San Antonio, Texas
8 (6) 1987 USA San Antonio, Texas 45M
9 (6) 1986 USA San Antonio, Texas 78M
10 (6) 1984 USA San Antonio, Texas 36F
11 (6) 1979 USA Pennsylvania 72F
12 (6) 1977 USA Maryland 80F
Case no. Clinical Alleged vector
1 Soft tissue infection right ankle
(professional pest controller)
2 Soft tissue infection right foot
3 (1) Multifocal soft tissue infections
(upper and lower limbs, abdomen),
4 (1) Multifocal soft tissue infections Spider
(upper and lower limbs)
5 (1) Cough and fever
6 (1) Multifocal soft tissue infections
(lower limbs and chest)
7 (6) Groin infection
8 (6) Multifocal soft tissue infection, Spider
left lower limb
9 (6) Multifocal soft tissue infection
left lower limb
10 (6) Disseminated bacterial infection
12 (6) Endocarditis
Case no. Source of isolate
1 Pus from ankle ulcer
2 Pus and tissue from
3 (1) Blood, sputum, pus
4 (1) Pus from soft tissue
5 (1) Blood
6 (1) Pus and soft tissue
7 (6) Groin
8 (6) Pus from lower
9 (6) Pus from lower limb
abscess and ulcer
10 (6) Submandible, abdomen
11 (6) Blood, skin
12 (6) Blood
(1.) Peel MM, Alfredson DA, Gerrard JG, Davis JM, Robson JM, McDougall RJ, et al. Isolation, identification, and molecular characterization of strains of Photorhabdus luminescens from infected humans in Australia. J Clin Microbiol 1999;37:3647-53.
(2.) Fischer-Le Saux M, Viallard V, Brunel B, Normand P, Boemare NE. Polyphasic classification of the genus Photorhabdus and proposal of new taxa: P. luminescens subsp, luminescens subsp. nov., P. luminescens subsp. akhurstii subsp. nov., P. luminescens subsp. laumondii subsp. nov., P. temperata sp. nov., P. temperata subsp. temperata subsp. nov. and P. asymbiotica sp. nov. Int J Syst Bacteriol 1999;49:1645-56.
(3.) Boemare N, Givaudan A, Brehelin M, Laumond C. Symbiosis and pathogenicity of nematode-bacterium complexes. Symbiosis 1997;22:21-45.
(4.) ffrench-Constant RH, Bowen DJ. Novel insecticidal toxins from nematode-symbiotic bacteria. Cell Mol Life Sci 2000; 57:828-33.
(5.) Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001;413:523-7.
(6.) Farmer JJ, Jorgensen JH, Grimont PAD, Ackhurst RJ, Poinar GO, Ageron E, et al. Xenorhabdus luminescens (DNA Hybridization Group 5) from human clinical specimens. J Clin Microbiol 1989;27:1594-1600.
(7.) Akhurst R, Smith K. Regulation and safety. In: Gaugler R, editor. Entomopathogenic hematology. New York: CABI Publishing; 2002. p. 311-32.
(8.) Bleakley BH, Chen X. Survival of insect pathogenic and human clinical isolates of Photorhabdus luminescens in previously sterile soil. Can J Microbiol 1999;45: 273-8.
Address for correspondence: John G. Gerrard, Director of Infectious Diseases, Gold Coast Hospital, Southport, Queensland, Australia; fax: 07 55706 137; e-mail: firstname.lastname@example.org
John G. Gerrard,* Samantha McNevin, ([dagger]) David Alfredson,* Ross Forgan-Smith, ([dagger]) and Neil Fraser ([double dagger])
* Gold Coast Hospital, Southport, Queensland, Australia; ([dagger]) Queensland Medical Laboratory, West End, Queensland, Australia; and ([double dagger]) Harbour City Family Practice, Gladstone, Queensland, Australia
Dr. Gerrard is Director of Infectious Diseases at the Gold Coast Hospital and a clinical senior lecturer at the University of Queensland, Australia. His research interests include clinical and laboratory aspects of emerging bacterial pathogens.
COPYRIGHT 2003 U.S. National Center for Infectious Diseases
COPYRIGHT 2003 Gale Group